Featured Research

from universities, journals, and other organizations

Use Of Medication For Enlarged Prostate Not Associated With Increased Risk Of Hip Fracture

Date:
October 7, 2008
Source:
JAMA and Archives Journals
Summary:
Use of a class of medications for treating an enlarged prostate, known as 5- reductase inhibitors, are not associated with an increased hip fracture risk, according to a new study.

Use of a class of medications for treating an enlarged prostate, known as 5-α reductase inhibitors, are not associated with an increased hip fracture risk, according to a new study.

Benign prostatic hyperplasia (BPH; an enlarged prostate) is a common condition in aging men. It has been estimated that more than 8 million U.S. men age 50 to 79 years will meet current guidelines for considering treatment options for BPH by 2010, according to background information in the article. Treatments for BPH include surgical procedures, minimally invasive procedures and medications.

Most often the first-line therapy is pharmacological, using either α-blockers, or 5-α reductase inhibitors (such as finasteride or dutasteride), which work through hormonal mechanisms. It is not clear how 5-α reductase inhibition affects long-term bone health.

Steven J. Jacobsen, M.D., Ph.D., of Kaiser Permanente Southern California, Pasadena, Calif., and colleagues examined the association between use of 5-α reductase inhibitors for BPH and occurrence of hip fracture. The study included 7,076 men, 45 years and older, who experienced a hip fracture between 1997-2006. Control patients were 7,076 men without a hip fracture during the study period. Electronic information on pharmaceutical use was used to identify use of finasteride from 1991 forward. During this period (1991 to 2006), finasteride was the only 5-α reductase inhibitor dispensed to study patients, and 109 case patients (1.5 percent) and 141 control patients (2 percent) had a history of any exposure to these compounds.

The researchers found that there was no dose-response relationship between exposure to 5-α reductase inhibitors when the exposure was stratified into levels of total exposure. Of the patients in the study, 2,547 (36 percent of the men with hip fracture) and 2,488 (35 percent of the men without hip fracture) had a prior diagnosis of BPH. The use of α-blockers was slightly greater in men with hip fracture (32 percent) compared with those without hip fracture (30 percent).

"These data suggest that 5-α reductase inhibitors do not confer a negative risk for bone health and in fact may lower the risk of hip fracture. While presumably this lower risk is related to hormonal mechanisms, further understanding of the biological mechanisms underlying this phenomenon may lead to new insights that can be exploited for preventive measures. The increased risk of fracture associated with recent receipt of an α-blocker highlights the need for careful [use] of these agents," the authors conclude.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Cite This Page:

JAMA and Archives Journals. "Use Of Medication For Enlarged Prostate Not Associated With Increased Risk Of Hip Fracture." ScienceDaily. ScienceDaily, 7 October 2008. <www.sciencedaily.com/releases/2008/10/081007172818.htm>.
JAMA and Archives Journals. (2008, October 7). Use Of Medication For Enlarged Prostate Not Associated With Increased Risk Of Hip Fracture. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2008/10/081007172818.htm
JAMA and Archives Journals. "Use Of Medication For Enlarged Prostate Not Associated With Increased Risk Of Hip Fracture." ScienceDaily. www.sciencedaily.com/releases/2008/10/081007172818.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins